1
项与 GSK-2241658A 相关的临床试验Study of GSK2241658A Antigen-Specific Cancer Immunotherapeutic in Patients With Unresectable and Progressive Metastatic Cutaneous Melanoma
The purpose of this study is to investigate the safety, immunogenicity and clinical activity of GSK2241658A antigen-specific cancer immunotherapeutic (ASCI) for the treatment of patients with non-operable and progressing metastatic cutaneous melanoma.
100 项与 GSK-2241658A 相关的临床结果
100 项与 GSK-2241658A 相关的转化医学
100 项与 GSK-2241658A 相关的专利(医药)
100 项与 GSK-2241658A 相关的药物交易